Randomized controlled trial to evaluate the efficacy of Sodium glucose transporter 2 inhibitor in peritonealdialysis patients

Not Applicable

Recruiting

• Conditions: D051436; Chronic Kidney Disease

• Registration Number: JPRN-jRCT1011210022
• Lead Sponsor: ishio Saori

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Patients who is over 20 years old
Patients diagnosed with type 2 diabetes
Patients from whom written informed consent was
obtained

Exclusion Criteria

Patients who undergo PD less than 3 months
Patients with unstable blood pressure
Patients deemed inadequate for monitoring
during study period, as determined by investigator
s.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BNP